Press Releases Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Market Closed - Nyse Other stock markets 01:30:08 18/05/2024 am IST			5-day change	1st Jan Change
89.16 ^USD	-1.06%		+2.81%	+16.92%

14/05	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	MT
13/05	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05	BU
Edwards Lifesciences: Q1 Earnings Snapshot	26/04	AQ
Edwards Lifesciences Reports First Quarter Results	26/04	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	18/04	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	08/04	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	08/04	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	03/04	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	11/03	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	26/02	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	23/02	BU
Edwards Lifesciences: Q4 Earnings Snapshot	07/02	AQ
Edwards Lifesciences Reports Fourth Quarter Results	07/02	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	02/02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	30/01	BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?	02/01	AQ
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	02/01	BU
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference	07/12	BU
CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION	27/23/27	PR
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION	26/23/26	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST